lenvatinib and Jaw-Diseases

lenvatinib has been researched along with Jaw-Diseases* in 1 studies

Other Studies

1 other study(ies) available for lenvatinib and Jaw-Diseases

Article	Year
Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study. European journal of cancer (Oxford, England : 1990), 2021, Volume: 150 Topics: Adverse Drug Reaction Reporting Systems; Aged; Angiogenesis Inhibitors; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Everolimus; Female; Glucocorticoids; Humans; Incidence; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pharmacovigilance; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Risk Assessment; Risk Factors	2021

Article

Year

Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study.

European journal of cancer (Oxford, England : 1990), 2021, Volume: 150

Topics: Adverse Drug Reaction Reporting Systems; Aged; Angiogenesis Inhibitors; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Everolimus; Female; Glucocorticoids; Humans; Incidence; Jaw Diseases; Male; Middle Aged; Osteonecrosis; Pharmacovigilance; Phenylurea Compounds; Protein Kinase Inhibitors; Quinolines; Risk Assessment; Risk Factors

2021